REFERENCES

Anderson HR, Poloniecki JD, Strachan DP, Beasley R, Bjorksten B, Asher MI. Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am J Public Health. 2001; 91:1126–1129.

Asher MI, Weiland SK. The International Study of Asthma and Allergies in Childhood (ISAAC). ISAAC Steeriing Committee. Clin Exp Allergy. 1998; 28 Suppl 5:52–66; discussion 90–91.


Black SB, Cherry JD, Shinefield HR, Fireman B, Christenson P, Lampert D. Apparent decreased risk of invasive bacterial disease after heterologous childhood immunization. Am J Dis Child. 1991; 145:746–769.

Blom L, Nystrom L, Dahlquist G. The Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia. 1991; 34:176–181.

Burstein JL, Fleisher GR. Does recent vaccination increase the risk of occult bacteremia? Pediatr Emerg Care. 1994; 10:138–140.


Classen JB. The timing of immunization affects the development of diabetes in rodents. Autoimmunity. 1996; 24:137–145.


Davidson M, Letson GW, Ward JI, Ball A, Bulkow L, Christenson P, Cherry JD. DTP immunization and susceptibility to infectious diseases. Is there a relationship? Am J Dis Child. 1991; 145:750–754.

DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, Vadheim CM, Black SB, Shinefield HR, Davis RL, Bohlke K. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics. 2001; 108:E112.


EURODIAB. Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group. Lancet. 2000; 355:873–876.


Farooqi IS, Hopkin JM. Early childhood infection and atopic disorder. Thorax. 1998; 53:927–932.

Feudtner C, Marcuse EK. 2001. Ethics and immunization policy: Promoting dialogue to sustain consensus. Pediatrics. 107(5):1158–1164.

Fisher BL. On behalf of National Vaccine Information Center. Letter to Kathleen Stratton. November 5, 2001.


Gellin BG, Maibach EW, Marcuse EK. 2000. Do parents understand immunizations? A national telephone survey. Pediatrics 106(5):1097–1102.

Grant EN, Wagner R, Weiss KB. Observations on emerging patterns of asthma in our society. J Allergy Clin Immunol 1999; 104:S1–9.

Griffin MR, Taylor JA, Daugherty JR, Ray WA. No increased risk for invasive bacterial infection found following diphtheria-tetanus-pertussis immunization. Pediatrics. 1992; 89:640–642.


Heijbel H, Chen RT, Dahlquist G. Cumulative incidence of childhood-onset IDDM is unaffected by pertussis immunization. Diabetes Care. 1997; 20:173–175.

Hiltunen M, Lonnrot M, Hyoty H. Immunisation and type 1 diabetes mellitus: Is there a link? Drug Saf. 1999; 20:207–212.

Hurwitz EL, Morgenstern H. Effects of diphtheria-tetanus-pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. J Manipulative Physiol Ther. 2000; 23:81–90.

Hyoty H, Hiltunen M, Reunanen A, Leinikki P, Vesikari T, Lounamaa R, Tuomilehto J, Akerblom HK. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group. Diabetologia. 1993; 36:1303– 1308.


IOM (Institute of Medicine). 1991. Adverse Events Following Pertussis and Rubella Vaccines. Washington, DC: National Academy Press.

IOM. 1994. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: National Academy Press.

IOM. 2000. Clearing the Air. Washington, DC: National Academy Press.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement